About Isolex

Isolex is a private limited company (BV/SRL) based in Vorst, founded in 2025. Its main activity is classified as "Installatie van isolatie". For the 2025 financial year, Isolex reported a loss of €30,950. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€30,939. Equity is negative (-€20,950): liabilities exceed assets.

Juridical situation
Normal situation
Company number
1021.835.117
Founding date
Founded on 02-04-2025
EUID number
BEKBOBCE.1021.835.117
Type of enterprise
Rechtspersoon
Location
Pierre Decosterstraat 96/B01 Vorst 1190 Entrepôt 5
Juridical form
BV — Private limited company (BV/SRL)
Activities
Signals
Negative equity
Reporting losses
Poor liquidity
Negative cashflow
Negative EBITDA

Financial ratios

Profit
€ -31K
Equity
€ -21K
Gross margin
€ -31K
Health
Solvability > 25%
-65.9%
Liquidity > 1.0
0.60
Profitability > 0%
147.7%
2025
Gross margin
€ -31K
EBITDA
€ -31K
Profit
€ -31K
Equity
€ -21K
Solvability
-65.88%
Debt
€ 53K
Cash
€ 455

Frequently asked questions

Answers to the most common questions about Isolex, based on official government data and the filed annual accounts.

What is the VAT number of Isolex?

The VAT number of Isolex is BE1021.835.117.

When was Isolex established?

Isolex was founded in 02-04-2025.

What is the official address of Isolex?

The official address of Isolex is Pierre Decosterstraat 96/B01 Vorst 1190 Entrepôt 5.

What is the legal form of Isolex?

The juridical form of Isolex is Private limited company (BV/SRL).

What is the annual revenue of Isolex?

The 2025 accounts of Isolex do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.

Is Isolex a reliable company?

Isolex is a registered Rechtspersoon with company number 1021.835.117 and can be verified through the official CBE database.

What is the credit limit of Isolex?

The estimated credit limit of Isolex is €0.

Is Isolex still active?

Isolex currently has the status "Normal situation" and is active.

Further reading

View all insights

Sources